Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX For Unresected Pancreatic Cancer: Comparative Effectiveness and Evaluation of Tumor Growth in Veterans.

Authors : Sigel K, Zhou M, Park YA, Mutetwa T, Girish N, Yeh C, et al.

Published : Seminars in Oncology, in press, 2021.

Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer.

Authors : Blagoev KB, Iordanov R, Zhou M, Fojo T, Bates SE.

Published : Oncotarget. 2021; 12:15-21. PMID: 33456710.

Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation.

Authors : Maitland ML, Wilkerson J, Karovic S, Zhao B, Flynn J, Zhou M, Hilden P, Ahmed FS, Dercle L, Moskowitz CS, Tang Y, Connors DE, Adam SJ, Kelloff G, Gonen M, Fojo T, Schwartz LH, Oxnard GR.

Published : Clin Cancer Res. 2020; 26:6464-6474. PMID: 32988968.

A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.

Authors : Leuva H, Sigel K, Zhou M, Wilkerson J, Aggen DH, Park YA, Anderson CB, Hsu TM, Langhoff E, McWilliams G, Drake CG, Simon R, Bates SE, Fojo T.

Published : Semin Oncol. 2019; 46:351-361. PMID: 31757478.

Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes.

Authors : Burotto M, Wilkerson J, Stein WD, Bates SE, Fojo T.

Published : Semin Oncol. 2019; 46: 83-99. PMID: 30738604.

Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.

Authors : Shustov A, Coiffier B, Horwitz S, Sokol L, Pro B, Wolfson J, Balser B, Eisch R, Popplewell L, Prince HM, Allen SL, Piekarz R, Bates S.